Ross\Johnson & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72K Buy
52
+2
+4% +$183 0.07% 50
2026
Q1
$5.13K Sell
50
-1
-2% -$113 0.09% 48
2025
Q4
$6.39K Hold
51
0.12% 44
2025
Q3
$6.83K Hold
51
0.13% 39
2025
Q2
$6.94K Sell
51
-12
-19% -$1.58K 0.14% 36
2025
Q1
$8.36K Buy
63
+16
+34% +$2.04K 0.14% 58
2024
Q4
$5.32K Buy
+47
New +$5.43K 0.12% 44

Other funds holding ABT

Ross\Johnson & Associates's ABT Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Abbott (ABT) stake by 4% in Q2 2026, buying an estimated $183 and bringing the position to 52 shares worth $4.72K. The position accounts for 0.07% of the portfolio, ranked #50.

Ross\Johnson & Associates first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.36K in Q1 2025. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Ross\Johnson & Associates held 52 shares of Abbott worth $4.72K as of Q2 2026.
  • Ross\Johnson & Associates bought 2 Abbott shares in Q2 2026, an estimated $183.
  • Abbott made up 0.07% of Ross\Johnson & Associates's portfolio in Q2 2026, its #50 holding.
  • Ross\Johnson & Associates first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Abbott position peaked at $8.36K in Q1 2025.
  • 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.